Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Estee Lauder Companies Inc (EL) vs Oscar Health Inc (OSCR) Price & Performance

Estee Lauder Companies IncTrade
Oscar Health IncTrade

Price performance (Past 24H)

Key statistics

Estee Lauder Companies Inc vs Oscar Health Inc — how do they compare? Estee Lauder Companies Inc trades at $87.47 (market cap $31.76B), while Oscar Health Inc trades at $28.29 (market cap $8.63B). The key difference: Estee Lauder Companies Inc is far larger — about 3.7× Oscar Health Inc's market cap, and Estee Lauder Companies Inc pays a 1.59% dividend while Oscar Health Inc pays none. Which is the better fit depends on your goals.

ELOSCR
Market Cap
$31.76B$8.63B
Sector
Consumer StaplesHealth
52-Week High
$119.61$32.18
52-Week Low
$67.23$10.85
Enterprise Value
$37.93B$4.99B
Dividend Yield
1.59%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Estee Lauder Companies Inc

Estée Lauder (EL) trades at $87.19, down 1.31% on the day, with a mixed technical picture showing bullish moving averages but neutral oscillators. The company faces fundamental challenges with a net loss of $1.13B in 2025 and negative profit margins, though recent quarters have consistently beaten EPS expectations. Analyst sentiment is divided with a Hold consensus and $91.67 price target, while institutional activity shows significant position changes including Bank of America's 950.9% stake increase in Q1 2026.

The stock presents a recovery opportunity with strong brand positioning and recent product launches like the Glimmer fragrance, but faces headwinds from declining revenues and profitability. Near-term catalysts include the upcoming Q2 2026 earnings report where EL is expected to post $0.3193 EPS. The key risk remains execution on margin improvement amid competitive pressures in the beauty sector.

Oscar Health Inc

OSCR trades at $27.97, up 1.08% today, with a bearish technical signal but strong recent earnings beats in Q1 and Q2 2026. The company reported record profitability and raised its full-year outlook, driven by membership growth and cost controls. Key support lies at $26, with resistance at $28. Revenue surged 70% year-over-year in H1 2026 to $4.9 billion, per PYMNTS on August 6, 2026.

Outlook is positive due to robust growth and margin expansion, but risks include execution challenges and competitive pressures. Analysts have a consensus price target of $32.50, with 27% buy ratings. The stock offers value with a P/S of 0.53, though net income volatility remains a concern.

Returns comparison

Trailing returns across standard periods

About Estee Lauder Companies Inc

Estee Lauder is the world leader in the global prestige beauty market, participating across skincare (56% of fiscal 2022 sales), makeup (26%), fragrance (14%), and haircare (4%) categories, with popular brands such as Estee Lauder, Clinique, MAC, La Mer, Jo Malone, Aveda, Bobbi Brown, Too Faced, Origins, Dr. Jart+, and The Ordinary. The firm operates in 150 countries, with 26% of fiscal 2022 revenue stemming from the Americas, 43% from Europe, the Middle East, and Africa, and 31% from Asia-Pacific. The company sells its products through department stores, travel retail, multi-brand specialty beauty stores, brand-dedicated freestanding stores, e-commerce, salons/spas, and perfumeries.

Read more on EL

About Oscar Health Inc

Oscar Health, Inc. is a health insurance company that utilizes a technology-driven approach to simplify the healthcare experience. The company offers individual, small-group, and Medicare Advantage plans, primarily through a platform that integrates technology, data, and design to provide members with a personalized, efficient healthcare journey. Oscar aims to lower costs and improve engagement by focusing on consumer-centricity and modernizing the traditional health insurance model.

Read more on OSCR